Lilly Immergluck to RNA, Messenger
This is a "connection" page, showing publications Lilly Immergluck has written about RNA, Messenger.
Connection Strength
0.038
-
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. J Infect Dis. 2023 12 20; 228(12):1662-1666.
Score: 0.038